Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.

Liu, Andy; Perumpail, Ryan B; Kumari, Radhika; Younossi, Zobair M; Wong, Robert J; Ahmed, Aijaz

Liu, Andy; Perumpail, Ryan B; Kumari, Radhika; Younossi, Zobair M; Wong, Robert J; Ahmed, Aijaz.

Afiliação

Liu A; Andy Liu, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Perumpail RB; Andy Liu, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Kumari R; Andy Liu, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Younossi ZM; Andy Liu, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Wong RJ; Andy Liu, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Ahmed A; Andy Liu, Albert Einstein College of Medicine, Bronx, NY 10461, United States.

World J Hepatol ; 7(29): 2871-9, 2015 Dec 18.

Article em En | MEDLINE | ID: mdl-26692331

Palavras-chave

Covert hepatic encephalopathy; Hepatic encephalopathy; Lactulose; Overt hepatic encephalopathy; Rifaximin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article